FTSE 100 Live: London blue-chips end a lacklustre session in the red

FTSE 100 ended a quiet session down 39 points at 10,862.50. Vistry fell about 9% on reports its credit insurance cover was cut. Legal & General slid after Citi downgraded it to sell on valuation, trimming 2026-27 remittance forecasts. Brent rose to about $85 amid Strait of Hormuz deal headlines; US Fed cut odds fell after weak jobs data.

Original reporting
Published Aug 10, 2026, 7:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 7:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FTSE 100 Live: London blue-chips end a lacklustre session in the red — source image
Decision brief

The 30-second read

$CCEPBearishMed
01

Why it matters

Company-specific moves are driven by broker actions: Citi downgrades L&G, BNP Paribas downgrades Coca-Cola HBC, Deutsche Bank upgrades Persimmon, and Vistry is linked to reduced credit insurance coverage. Macro risk is centered on the upcoming US CPI print and oil-driven inflation expectations.

02

Market read

Traders get actionable single-name catalysts from broker actions and a credit-insurance coverage report, while the broader tape remains hostage to US CPI and oil headline risk.

03

What to watch

The article’s key macro driver is US CPI timing, and oil headline risk can quickly reverse; broker notes may already be partially priced given the summer malaise framing.

Relevance 6/10Novelty 5/10Timing: during London trading session, with US CPI and jobs debate as the next macro catalyst

Background

The FTSE 100 ends lower in a dull session as traders weigh weak US jobs data against the probability of a Fed cut, with Brent supported by Strait of Hormuz uncertainty.

Company-level read

Ticker impact

$CCEPBearishMedium confidence
Context

Coca-Cola HBC leads FTSE losers after a BNP Paribas downgrade to neutral, weighing on the stock during the session.

Expected impact

Limited upside until either estimates stabilize or another catalyst emerges; downside likely to persist intraday.

Evidence & confidence

The article ties the decline to a named downgrade, but does not provide new fundamentals beyond the call change.

Market effects

Housebuilders and insurers show sensitivity to credit and pension/volume assumptions, while broker downgrades/upgrades can dominate in a low-liquidity tape.

FTSE weakness is framed as a London-specific drift amid muted US futures, suggesting limited index-level follow-through absent a macro surprise.

Brent’s rise tied to Strait of Hormuz headlines reinforces inflation sensitivity ahead of US CPI, potentially affecting global rate expectations and cyclicals.

Counterpoint

Index-level weakness may be more about liquidity and macro positioning than company fundamentals, so single-name broker moves could mean-revert if CPI comes in cooler.

Key entities

  • Vistry

    Housebuilder cited as falling sharply on reports of reduced credit insurance cover.

  • Legal & General

    Insurer cited as down after Citi downgraded it to sell and trimmed remittance forecasts.

  • Coca-Cola HBC

    Drinks and logistics group cited as leading FTSE losers after BNP Paribas downgrade.

  • Persimmon

    Housebuilder cited as upgraded by Deutsche Bank to buy, despite a lower target price.

  • Brent crude

    Rising on Strait of Hormuz headline risk, feeding into inflation expectations ahead of CPI.

Related articles

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

$CCEPMed

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported first-half 2026 results on an earnings call. Revenue rose 6.1% to EUR 10.7B, operating profit increased 8.1% to EUR 1.5B, and diluted EPS rose 10.6% to EUR 2.20. Free cash flow was EUR 435M, with full-year guidance reaffirmed and EUR 600M of a EUR 1B buyback completed.

$CCEPMed

Coca-Cola Europacific shares lose fizz after interim results

Coca-Cola Europacific Partners reported higher first-half profit and reaffirmed 2026 guidance, but shares fell 4.3% to 7,710p after interim results. Revenue rose 4.4% to €10.7bn, operating profit increased 6.9% to €1.5bn, and diluted EPS grew 9.1% to €2.17. Guidance: currency-neutral revenue growth 3% to 4%, operating profit growth around 7%, free cash flow at least €1.7bn.